Login / Register
Follow us on Facebook
Follow us on Twitter
News & Analysis
Economy & Policy
Hybrids & EVs
Concepts & Rumors
Best & Worst
Health & Fitness
Home & Living
Articles About generic drugs
April 08, 2015
7 OTC Drugs That You Should Always Buy Generic
One easy way for people to cut costs in health spending is to switch from name-brand drugs to cheaper, store-brand versions of the same products.
May 27, 2014
3 Reasons to be Bullish on Teva Pharmaceutical
Teva has had a rough year so far, but analysts remain bullish on this pharmaceutical company.
May 20, 2014
Which Do You Want First? Teva Pharmaceutical’s Good and Bad News
Teva's last-ditch effort to salvage its blockbuster multiple sclerosis drug, Copaxone, has failed. Despite that, good things seem to be ahead for the drugmaker.
May 13, 2014
In Last-Ditch Effort to Salvage Blockbuster Drug, Teva Sues the FDA
With its patent expiry date looming, Teva has decided to sue the U.S. Food and Drug Administration to buy time for Copaxone, one of its top-selling medicines.
April 17, 2014
Generic Drugmakers Fight Teva’s Bid to Stall Competition
Several generic drugmakers have banded together to ask the Supreme Court to allow them to market generic versions of Teva's Copaxone in the U.S.
April 17, 2014
6 Ways You Can Save Money on Health Costs
Health expenses can really add up quickly, even with good insurance. Luckily, there are many ways to save money on office visits and health costs.
April 11, 2014
CVS Caremark: People Spent More on Specialty Medicines in 2013
CVS Caremark's annual "Insights" report found that spending on specialty medicines increased by more than 22 percent in 2013, driving the prescription drug trend.
April 04, 2014
Supreme Court Studies Generic Drug Question: How Will Patients Fare?
Teva Pharmaceutical Industries -- the world’s largest manufacturer of generic drugs -- has criticized brand-name drug-makers for trying to block its generic versions.
March 31, 2014
FTC Takes Drugmakers to Court, Says Generic Delays Are Hurting Consumers
The Federal Trade Commission is suing a handful of pharmaceutical companies that delay generic versions of drugs.
March 13, 2014
Here’s Why Pfizer’s Holding on to Its Celebrex Patent With Both Hands
For Pfizer, like many large drug manufacturers, cheaper generic versions of its once-top-selling pharmaceuticals are eroding sales for drugs.
March 03, 2014
Teva’s New Version of Copaxone Could Be a Tough Bet for Insurers
Teva may find its new formula of Copaxone is a tough sell for insurers; the company is desperate to convert patients.
February 14, 2014
Pfizer Unit Sued by Regulator for ‘Deterring Competition’
Pfizer's Australian unit is being sued by a federal regulator there for allegedly deterring competition of its generic version of the top-selling Lipitor.
February 11, 2014
Merck Aims to Be First to the Finish Line With Generic of Lantus
Merck & Co. Inc. announced Monday that it's partnering with Samsung Bioepis to create a generic version of Sanofi SA's best-selling insulin drug.
February 07, 2014
Pfizer Wins Exclusivity on Lyrica Until 2018
Pfizer won a court ruling that effectively blocks generic competition for its top-selling pain medicine, Lyrica, until December 2018.
January 21, 2014
Here’s a Deep Dive Into Rite Aid Stock
The room that’s present for Rite Aid to improve operationally implies that it will continue to trade higher.
January 16, 2014
J&J Continues ‘Strategic Pruning’ With This Divestiture
Private equity firm Carlyle Group said it purchased Johnson & Johnson’s Ortho-Clinical Diagnostics unit for $4.15 billion.
January 07, 2014
Eli Lilly Stares Down Barrel of Patent Expirations and Generic Competition
Eli Lilly is facing increasing competition from generic versions of some of its top-selling drugs, and the company has predicted a decline in sales for 2014.
January 06, 2014
Walgreens’ December Sales Rose Higher Despite New Generic Drugs
Walgreens same store sales rose 6.1 percent in the month of December despite factors such as new generic drugs that hurt pharmacy sales.
December 19, 2013
Pfizer’s Viagra Going Generic: Cheaper Options Coming Soon
Pfizer's erectile dysfunction treatment is set to go generic.
October 23, 2013
Glaxo’s China Bribery Backlash
GlaxoSmithKline reported earnings on Wednesday that showed the pharmaceutical company has been hit hard by its bribery scandal in China earlier this year.
June 22, 2013
Healthcare Costs Are Falling, But Will That Trend Survive Obamacare?
Healthcare costs for United States consumers dropped in May for the first time in almost four decades.
June 12, 2013
Aggressive Tactics Proved Too Risky For These Generic Drugmakers
Teva Pharmaceutical and Sun Pharmaceutical agreed Wednesday to pay $2.15 billion in patent-infringement damages to Pfizer and Takeda Pharmaceutical.
January 13, 2012
Class Action Suit Accuses Walgreen, Par Pharmaceutical of Overcharging Conspiracy
A union benefits fund has filed a class action lawsuit against Walgreen and Par Pharmaceutical Companies accusing them of having engaged in "at least two widespread schemes to overcharge" for generic drugs...
//get_template_part('includes/content', 'mini_store'); ?>
the Cheat Sheet
Like Us on Facebook
Follow Us on Twitter